BridgeBio Oncology Therapeutics, Inc. (BBOT) › Operating Cash FlowBridgeBio Oncology Therapeutics, Inc. (BBOT) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2024: -$55.03M2025: -$113.89M-$113.89M2024Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$113.89M-107.0%2024-$55.03M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share